Obstructive Sleep Apnea News and Research

RSS

Obstructive sleep apnea (OSA) is a major heath problem. In the United States, at least 17 million people have moderate to severe OSA, which is characterized by heavy snoring, airway blockage and frequent awakenings during sleep.

Surgery may not be the best option for children with obstructive sleep apnea

For children with obstructive sleep apnea, standard care often includes a tonsillectomy and adenoidectomy. But researchers at Saint Louis University say further research is needed to determine if surgery is the best option for these patients.

5 Nov 2009

Nasal positive airway pressure therapy for sleep apnea golfers may improve their game

Golfers who undergo treatment for sleep apnea may improve their golf game as well as their overall health, shows new research. A new study presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that golfers with obstructive sleep apnea (OSA) who received nasal positive airway pressure (NPAP) for their disorder improved their daytime sleepiness scores and lowered their golf handicap by as much as three strokes.

3 Nov 2009

NUVIGIL improves wakefulness in patients with excessive sleepiness associated with shift work disorder

Cephalon, Inc. today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL® (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder (SWD).

3 Nov 2009

High prevalence of nocturnal teeth grinding in patients with OSA

There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.

3 Nov 2009

Contour Products promotes the results of a 2009 survey conducted among respiratory therapists

In conjunction with National Respiratory Care Week, Contour Products(TM), a leader in the sleep support and comfort industry, is proud to promote the results of a 2009 survey conducted among respiratory therapists who work with CPAP patients daily. One of the most common issues among CPAP therapy users is discomfort when sleeping with their CPAP mask, as a result of the mask pressing against their face.

28 Oct 2009

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Circadiance, the leader in soft-cloth nasal CPAP masks, announces the new Zzzephyr Seal, a revolutionary elastic cloth seal designed to fit more comfortably over the patient's nose. The lightweight seal reduces air leakage, and helps to ensure a better night's sleep for Obstructive Sleep Apnea patients.

26 Oct 2009

Continucare acquires two additional centers

Continucare Corporation (NYSE Amex:CNU) announced today that it has expanded its sleep diagnostic division with the acquisition of two additional centers. Seredor Corporation, Continucare’s newly established subsidiary, has purchased the assets of Sleep Disorder Solutions, Inc., a full service operator of sleep diagnostic centers, with sleep diagnostic centers in South Miami and Pembroke Pines, Florida.

23 Oct 2009

SNAP Diagnostics joins SAFE-BioPharma Association

SNAP Diagnostics, a Chicago-based leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns, has joined SAFE-BioPharma Association, the non-profit association that created and manages the global SAFE-BioPharma® digital identity and signature standard for the pharmaceutical and healthcare industries. SNAP Diagnostics is the first dedicated device and diagnostics company to join SAFE-BioPharma.

22 Oct 2009

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

The Institute for Health Technology Studies (InHealth) has awarded three new research grants totaling more than $1.4 million to investigators at the University of Southern California, Northwestern University, and Stanford University. The funding will support three separate studies that will examine the social and economic impact of therapeutic medical devices, as well as the device innovation process.

22 Oct 2009

Diet and exercise program unlikely to eliminate OSA in overweight patients

A study in the Oct. 15 issue of the Journal of Clinical Sleep Medicine found that while a strict diet and exercise program may benefit obese patients with mild to moderate obstructive sleep apnea (OSA), it is unlikely to eliminate the condition.

15 Oct 2009

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Nearly all patients who underwent surgery to treat oropharyngeal cancer experienced some degree of obstructive sleep apnea (OSA), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.

7 Oct 2009

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

PEAK Surgical, Inc. and Medtronic, Inc. (NYSE: MDT) today announced an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade® TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat (ENT) market.

6 Oct 2009

ResMed announces acquisition of Laboratoires Narval

ResMed Inc. (NYSE: RMD), a leading developer, manufacturer and distributor of sleep and respiratory medical equipment, announced today that it has acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.

From ResMed Corp 6 Oct 2009

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

Today, at the American Academy of Otolaryngology-Head and Neck Surgery annual meeting, ImThera Medical, Inc. unveiled its new product, the aura6000™ neurostimulation system for the treatment of Obstructive Sleep Apnea (OSA).

5 Oct 2009

GI tract conditions can occur in sleep apnea patients

Patients who suffer from obstructive sleep apnea (OSA) also tend to have additional gastrointestinal (GI) tract conditions, such as gastric reflux and hiatal hernia, which form at the opening in your diaphragm where your food pipe (esophagus) joins your stomach.

5 Oct 2009

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Patients who suffer from both allergic rhinitis and obstructive sleep apnea (OSA) may experience escalated symptoms of stress and fatigue.

5 Oct 2009

Radiofrequency ablation used to treat snoring patients

Radiofrequency ablation, a procedure that uses heat to shrink the tissue of the soft palate, is an effective and minimally invasive procedure that can be used to treat patients who snore.

5 Oct 2009

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

ImThera Medical, Inc. has received Ethics Committee clearance to begin human clinical trials in Belgium. The trials will include ImThera’s Targeted Hypoglossal Neurostimulation (THN) Sleep Therapy to treat Obstructive Sleep Apnea (OSA). Along with the clinical trial approvals, ImThera has received ISO 13485 certification of its quality system as a pre-requisite for the future CE mark application for European commercialization of medical products.

1 Oct 2009

FDA grants priority review for Cephalon's sNDA

Cephalon, Inc. today announced the U.S. Food and Drug Administration (FDA) has granted a priority review for its supplemental New Drug Application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV], which was filed in June of this year.

25 Sep 2009

ImThera Medical completes THN system development

ImThera Medical, Inc. announced today that it has completed development of its Targeted Hypoglossal Neurostimulation (THN) system for Obstructive Sleep Apnea (OSA).

24 Sep 2009

Obstructive Sleep Apnea News and Research

Further Reading

Surgery may not be the best option for children with obstructive sleep apnea

Nasal positive airway pressure therapy for sleep apnea golfers may improve their game

NUVIGIL improves wakefulness in patients with excessive sleepiness associated with shift work disorder

High prevalence of nocturnal teeth grinding in patients with OSA

Contour Products promotes the results of a 2009 survey conducted among respiratory therapists

New lightweight, elastic cloth seal for Obstructive Sleep Apnea patients

Continucare acquires two additional centers

SNAP Diagnostics joins SAFE-BioPharma Association

InHealth awards Southern California, Northwestern and Stanford Universities $1.4M as research grants

Diet and exercise program unlikely to eliminate OSA in overweight patients

Study: Patients experience sleep apnea after opharyngeal cancer treatment

Medtronic receives global distribution rights for PEAK Surgical’s tissue dissection device

ResMed announces acquisition of Laboratoires Narval

ImThera Medical launches the aura6000 neurostimulation system for treating Obstructive Sleep Apnea

GI tract conditions can occur in sleep apnea patients

Patients suffering from allergic rhinitis experience escalated symptoms of stress and fatigue

Radiofrequency ablation used to treat snoring patients

Imthera Medical receives Ethics Committee clearance to start human clinical trials in Belgium

FDA grants priority review for Cephalon's sNDA

ImThera Medical completes THN system development

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News